Geron Corporation (Nasdaq:GERN) and Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation (NYSE:CBM), announced today an agreement for the manufacture of Geron's GRNVAC1 telomerase vaccine. The agreement provides for the transfer of Geron's vaccine production process to Cambrex and the cGMP manufacture of GRNVAC1 by Cambrex.
